11 marzo 2015
Implantable defibrillators, along with other modern treatments, have reduced mortality rates and are helping patients with hypertrophic cardiomyopathy live longer, a study confirms. This research ‘changes our perceptions of HCM from a grim, unrelenting, and largely untreatable condition to a contemporary disease with effective treatment options and a low rate of death,’ states the lead researcher.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/X4ayOWoDnIw/150311160523.htm
